| Issue | Title | Abstract | File |
| No 13S (2018) | 2017 Events (from open information sources) | Abstract |
 (Rus) |
| Article E. | |||
| No 9 (2020) | 3D printing in pharmacy | Abstract |
(Rus) |
| Prozherina Y. | |||
| No 9 (2020) | A breakthrough in the treatment of chronic lymphocytic leukemia | Abstract |
(Rus) |
| Prozherina Y., Shirokova I. | |||
| No 1-3 (2020) | A comparative characteristic of business models of leading pharmaceutical manufacturers: aspects of commercial activities | Abstract |
(Rus) |
| Yasinskaya L.E., Trofimova E.O. | |||
| No 4-6 (2020) | A comparative characteristic of business models of leading pharmaceutical manufacturers: aspects of investment activities | Abstract |
(Rus) |
| Yasinskaya L.E. | |||
| No 2 (2021) | A current approach to the treatment of ulcerative colitis: updated recommendations of the American Gastroenterological Association | Abstract |
(Rus) |
| Vodovozov A. | |||
| No 3 (2018) | A new step in the treatment of «king's diseases» | Abstract |
(Rus) |
| Shirokova I., Prozherina J. | |||
| No 1 (2022) | A rational approach to the issue of responsible self-treatment through the prism of pharmaceutical counseling | Abstract | |
| Oleinikova T.A., Baribina E.S. | |||
| No 2 (2021) | A review of tender purchases of L01 group – antineoplastic agents | Abstract |
(Rus) |
| Kalinina N. | |||
| No 3 (2021) | A structural analysis of sales of drugs for the treatment of chronic hepatitis C in the Russian market | Abstract |
(Rus) |
| Tsitlionok E.A., Narkevich I.A., Nemyatykh O.D., Siukaeva D.D., Grinyuk A.S., Lisachenko V.O. | |||
| No 4 (2019) | A STUDY OF FACTORS INFLUENCING PHARMACEUTICAL COUNSELING IN VIETNAMESE COMMUNITY PHARMACIES | Abstract |
(Rus) |
| Dorofeeva V.V., Tran V.D. | |||
| No 3 (2025) | A study of the awareness of the penza region population about the prevention and manifestation of osteoporosis | Abstract |
(Rus) |
| Pronkina A.A., Glembotskaya G.T., Tyugaeva G.A. | |||
| No 3 (2022) | A word about “Soviet penicillin” | Abstract |
(Rus) |
| Sherstneva E.V. | |||
| No 2 (2024) | Acceleration programs as a mechanism of innovation development in the healthcare sector | Abstract |
(Rus) |
| Tsvetkov D.V., Snegireva Y.Y. | |||
| No 4 (2023) | Accessibility of medical care for adult cancer diseases using off-label drugs: clinical recommendations and standards of medical care analysis | Abstract |
(Rus) |
| Ledovskikh Y.A. | |||
| No 4 (2024) | Accessibility of otorhinolaryngological care to the children's population in public and private medical organizations | Abstract |
(Rus) |
| Oleinik A.V. | |||
| No 1 (2022) | Activities of municipalities in the field of drug provision of the population in Russia in the second half of the XIX - early XX century | Abstract | |
| Sherstneva E.V., Egorysheva I.V. | |||
| No 1 (2024) | Actual questions of ensuring accessibility of primary health care for the adult population (review) | Abstract |
(Rus) |
| Dzhurinsky M.O., Ogneva E.Y. | |||
| No 4-6 (2020) | Advances in synthetic biology and regulatory policy of the state | Abstract |
(Rus) |
| Mokhov A.A., Chaplenko A.A., Yavorskiy A.N. | |||
| No 12 (2018) | Advertising in the pharm market: evaluation of 2018 practice and forecasts for self-regulation | Abstract |
(Rus) |
| Borzova M. | |||
| No 12 (2019) | Advertising of prescription drugs: when you can’t have everything and even more | Abstract |
(Rus) |
| Borzova M. | |||
| No 11 (2019) | Ad\"yuvanty - nastoyashchee i budushchee vaktsin | Abstract |
(Rus) |
| Shirokova I. | |||
| No 11-12 (2020) | Affordable and modern antithrombotic therapy for atrial fibrillation | Abstract |
(Rus) |
| Kalinina N. | |||
| No 11-12 (2020) | Agile stockpiles an insurance for drug supply | Abstract |
(Rus) |
| Gilissen E., Mulligan C., Tottman S., Troein P. | |||
| No 11 (2018) | Aleksandr Ametov: instrumentom importozameshcheniya dolzhen stat' gosudarstvennyy registr sakharnogo diabeta | Abstract |
(Rus) |
| Article E. | |||
| No 7-8 (2020) | Aleksandr TIKhOMIROV: «Nuzhno nachinat' lechenie kak mozhno ran'she, chtoby potom ne «dogonyat'» tyazheluyu voskhodyashchuyu infektsiyu» | Abstract |
(Rus) |
| Article E. | |||
| No 10 (2020) | Ambulatornye patsienty s koronavirusom poluchat favipiravir besplatno | Abstract |
(Rus) |
| Article E. | |||
| No 3 (2024) | Analysis and evaluation of the digital transformation of the healthcare system, problems of implementation (scientific review) | Abstract |
(Rus) |
| Davronov I.V., Suslonova N.V., Garanina I.A. | |||
| No 3 (2022) | Analysis of blood glucose and cholesterol indicators in university students in Kazan for 2018-2020 based on the results of preventive medical examinations | Abstract |
(Rus) |
| Mazitov M.R., Shulaev A.V., Ziatdinov A.I., Ganeev K.A. | |||
| No 5 (2019) | Analysis of compliance with the rules of vacation prescription medicines from pharmacies | Abstract |
(Rus) |
| Moroz T.L., Ryzhova O.A. | |||
| No 7-8 (2020) | Analysis of current issues for development of pharmaceutical products export in the russian federation: the case of biotechnology enterprise | Abstract |
(Rus) |
| Trukhin V.P., Narkevich I.A., Nacharova E.P., Basakina I.I., Poliakova I.N. | |||
| No 1 (2025) | Analysis of demand and supply of cholesteric drugs in the pharmaceutical market | Abstract |
(Rus) |
| Айдова А.В., Шакирова Д.Х., Сафиуллин Р.С., Абдулхаков С.Р. | |||
| No 5 (2018) | Analysis of development trends of the pharmaceutical market of non-steroidal anti-inflammatory drugs in Russia | Abstract |
(Rus) |
| Oleynikova T.A., Pozhidaeva D.N. | |||
| No 1 (2024) | Analysis of drug safety risk factors in medical organizations of Moscow in 2020 2022 | Abstract |
(Rus) |
| Kuznetsova E.V., Zhuravleva M.V., Mikhailov I.A., Khabriev R.U. | |||
| No 3 (2023) | Analysis of factors determining satisfaction with the work of employees in pharmaceutical organizations | Abstract |
(Rus) |
| Alahmad A., Spichak I.V., Zhirova I.V., Ballul G. | |||
| No 7-8 (2020) | Analysis of foreign experience in training personnelfor the pharmaceutical industry in the European Union | Abstract |
(Rus) |
| Budenkova E.A., Litvinova T.M. | |||
| No 3 (2024) | Analysis of legal regulation of medical mentoring | Abstract |
(Rus) |
| Grishina N.K., Bobrovich I.V. | |||
| No 4 (2019) | ANALYSIS OF PATENT PORTFOLIOS IN THE ANTI-INFLUENZA DRUG SEGMENT | Abstract |
(Rus) |
| Vyukhin M., Rodnin A., Shulgin V. | |||
| No 12 (2018) | Analysis of patent portfolios of anticancer drugs | Abstract |
(Rus) |
| Viukhin M., Shulgin V., Bushueva M. | |||
| No 11-12 (2020) | Analysis of performance indicators of the High-cost Nosologies program in the constituent entities of the Russian Federation | Abstract |
(Rus) |
| Petrukhina I.K., Yagudina R.I., Ryazanova T.K., Gladunova E.P., Egorova A.V., Khusainova A.I., Blinkova P.R., Loginova L.V. | |||
| No 2 (2024) | Analysis of pharmaceutical professionals’ competence in advising the public on skin burn treatment | Abstract |
(Rus) |
| Ulianova I.E., Egorova S.N. | |||
| No 4 (2024) | Analysis of scientometric indicators of the Moscow Healthcare Department scientific organizations in subject areas of the category Medicine | Abstract |
(Rus) |
| Starshinin A.V., Tarkhov K.Y. | |||
| No 2 (2023) | Analysis of the assortment of medicinal herbal preparations for veterinary use presented on the Russian pharmaceutical market | Abstract |
(Rus) |
| Zanina I.A., Evsikov F.D. | |||
| No 2 (2025) | Analysis of the assortment of medicinal products containing glucocorticosteroids for the pharmacotherapy of atopic dermatitis in pediatrics | Abstract |
(Rus) |
| Salnikova A.G., Dianova D.G. | |||
| No 3 (2022) | Analysis of the budget expenditure for rare diseases in the subjects of the Russian Federation | Abstract |
(Rus) |
| Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y. | |||
| No 4 (2022) | Analysis of the completeness of the russian market of over-the-counter medicines for the treatment of neurotic disorders | Abstract |
(Rus) |
| Oleynikova T.A., Barybina E.S. | |||
| No 7-8 (2019) | Analysis of the drug assortment for palliative care for children in the Russian Federation | Abstract |
(Rus) |
| Narkevich I.A., Nemyatykh O.D., Medvedeva D.M., Vrubel E.T. | |||
| No 2 (2023) | Analysis of the efficiency of colorectal cancer diagnostics in patients with malignant neoplasms detected for the first time | Abstract |
(Rus) |
| Naygovzina N.B., Patrushev M.A. | |||
| No 13S (2018) | Analysis of the FFP Tender Market in 2017 | Abstract |
(Rus) |
| Article E. | |||
| No 1 (2023) | Analysis of the influence of the level of education and work experience of pharmaceutical workers on interaction with teenage buyers | Abstract |
(Rus) |
| Sinitsyna A.A., Denisova M.N., Litvinova T.M. | |||
| No 7-8 (2020) | Analysis of the market of products based on plant-based raw materials used in urology | Abstract |
(Rus) |
| Safonova N.V., Trofimova E.O. | |||
| No 1 (2023) | Analysis of the range of veterinary pharmaceutical organizations in Moscow | Abstract |
(Rus) |
| Deltsov A.A., Kosova I.V., Rodkina O.R. | |||
| No 10 (2019) | Analysis of the Russian paediatric antibacterials market | Abstract |
(Rus) |
| Narkevich I.A., Nemyatykh O.D., Medvedeva D.M., Ladut'ko Y.M., Terninko T.M., Zagalov D.E., Mikhaylova Y.V. | |||
| No 2 (2023) | Analysis of the State Pharmacopoiea’s of the Russian Federation requirements’ coverage of drug products and drug substance of different origin and drug products included in the list of vital and primary drug products | Abstract |
(Rus) |
| Yarutkin A.V., Bagirova V.L., Berezhnaya E.S. | |||
| No 4 (2023) | Andragogy in the context of training specialists of the capital's healthcare | Abstract |
(Rus) |
| Starshinin A.V., Aksenova E.I., Kamasheva A.V., Filatova M.Y., Kuraeva V.M. | |||
| No 3 (2021) | Andrey DANILOV: «Khronicheskaya bol' – eto uzhe ne epidemiya, a pandemiya» | Abstract |
(Rus) |
| - -. | |||
| No 1-3 (2020) | Andrey Danilov: «Ser'eznoy problemoy ostaetsya pravil'noe ponimanie prirody khronicheskoy boli» | Abstract |
(Rus) |
| Article E. | |||
| No 11-12 (2020) | Anticoagulant group tender review | Abstract |
(Rus) |
| Kalinina N. | |||
| No 4-6 (2020) | Antipsychotic drugs market: issues of regional procurement | Abstract |
(Rus) |
| Prozherina Y. | |||
| No 10 (2020) | AnviMax®: optimal drug to combat ARVI and influenza | Abstract |
(Rus) |
| Kalinina N. | |||
| No 1 (2022) | Application of the ATC/DDD methodology in predicting the need for genetically engineered biological products used to treat patients with rheumatic diseases in a hospital setting | Abstract | |
| Ugoltsova V.N., Shakirova D.K., Abdulganieva D.I., Safiullin R.S. | |||
| No 1 (2023) | Applications of some biodegradable polymers in medicine | Abstract |
(Rus) |
| Abbasov I.B. | |||
| No 3 (2023) | Approaches to evaluating the effectiveness of the pharmacovigilance system in the Republic of Kazakhstan | Abstract |
(Rus) |
| Taube A.A., 2 . | |||
| No 11 (2018) | Armais Kamalov: «Segodnya ochen' vazhno sfokusirovat' vnimanie na aktivnom dolgoletii muzhchin» | Abstract |
(Rus) |
| Article E. | |||
| No 4 (2018) | Artificial intelligence in health care: the system problems | Abstract |
(Rus) |
| Kolesnichenko O.Y., Kolesnichenko Y.Y., Litvak D... | |||
| No 1-3 (2020) | Assessing the relationship between deviations from GMP requirements and potential quality defects of medicinal products:a survey of employees of the pharmaceutical inspectorate | Abstract |
(Rus) |
| Orlov V.A., Shestakov V.N. | |||
| No 3 (2024) | Assessment of efficiency of medicine and health care: current state of the problem | Abstract |
(Rus) |
| Kaprin D.A. | |||
| No 1 (2022) | Assessment of problems in the organization of day hospitals | Abstract | |
| Fayzullina R.N., Gilmanov A.A., Iskandarov I.R. | |||
| No 4 (2024) | Assessment of the impact of «evergreening patients» on the budget segment of the Russian pharmaceutical market | Abstract |
(Rus) |
| Denisova M.N., Nadelyaeva I.I. | |||
| No 3 (2024) | Assessment of the importance and need for longevity students of certain regions of the Russian Federation | Abstract |
(Rus) |
| Федоткина С.А., Ахминеева А.Х., Музалева О.В., Овсянникова Е.Г., Дорфман Ю.Р. | |||
| No 3 (2024) | Assessment of the state of medical care for cancer patients in the Kyrgyz Republic | Abstract |
(Rus) |
| Ibraimova D.D. | |||
| No 1 (2022) | Assortment analysis of the pharmaceutical online market of over-the-counter drugs for external use in thermal burns | Abstract | |
| Lukoyanova I.E., Egorova S.N. | |||
| No 2 (2021) | Atrial fibrillation: key aspects of therapy and place of DOAC | Abstract |
(Rus) |
| Prozherina Y. | |||
| No 4 (2024) | B. E. Peterson (1923–1981) is one of the founders of Russian oncology | Abstract |
(Rus) |
| Ганцев Ш.Х., Кзыргалин Ш.Р., Балыкина А.Е. | |||
| No 4 (2024) | Basic questionnaires to assess the quality of life in patients with multiple sclerosis | Abstract |
(Rus) |
| Andreev D.A. | |||
| No 11 (2019) | Bayer v dialoge s rossiyskimi spetsialistami zdravookhraneniya | Abstract |
(Rus) |
| Article E. | |||
| No 7-8 (2020) | Beyond the Future | Abstract |
(Rus) |
| Prozherina Y. | |||
| No 1 (2024) | Bibliometric analysis of the results of intellectual activity (using the example of dissertations in psychiatry) | Abstract |
(Rus) |
| Shport S.V., Eminova V.S. | |||
| No 12 (2019) | Big Data Analytics of EHRs: pathogenic relations of cancer with Ischaemic Heart Disease and Diabetes Mellitus | Abstract |
(Rus) |
| Kolesnichenko O.Y., Kolesnichenko Y.Y., Pulit V.V., Martynov A.V., Sotnik A.Y., Khaykina I.A., Marochkina E.B., Minushkina L.O., Pimenova K.V., Bugakova A.S., Vasilyeva E.Y., Komarov R.N., Golovanov A.V. | |||
| No 4 (2021) | Biocompatible drugs-protectors against radiation exposure: a modern view on the problem | Abstract | |
| Khabriev R.U., Mingazova E.N., Sidorov V.V., Gureev S.A., Yusupova M.M. | |||
| No 4 (2024) | Bioeconomical trends in modern medicine (literature review) | Abstract |
(Rus) |
| Borshchuk E.L., Bulycheva E.V., Begun D.N., Zudin A.B. | |||
| No 3 (2021) | Biosimilars: evolution of approaches to the development, regulation, life cycle control and interchangeability management | Abstract |
(Rus) |
| Niyazov R.R., Dranitsyna M.A., Vasiliev A.N., Gavrishina E.V. | |||
| No 2 (2021) | Biosimilars: reproduction of the clinical profile using modern biotechnology | Abstract |
(Rus) |
| Niyazov R.R., Dranitsyna M.A., Vasiliev A.N., Gavrishina E.V. | |||
| No 1-2 (2019) | Blood glucose meters and test strips: pharmacy market | Abstract |
(Rus) |
| Prozherina J. | |||
| No 6 (2018) | Brief review of judicial practice in the sphere of manufacturing and handling medical products for the period from february to May 2018 | Abstract |
(Rus) |
| Borzova M. | |||
| No 1 (2022) | Bringing registration dossiers in line with the requirements of the EAEU is the number one priority for pharmaceutical industry enterprises | Abstract | |
| Plotnikov A.V., Koroleva T.A. | |||
| No 9 (2020) | Bronchial asthma: fundamental changes in the new GINA guidelines(2019) | Abstract |
(Rus) |
| Vodovozov A. | |||
| No 13S (2018) | Budget segment (exclusive of subsidized drug coverage) | Abstract |
(Rus) |
| Article E. | |||
| No 12 (2019) | Budget segment of the PD market in Russia: results for 9 months of 2019 | Abstract |
(Rus) |
| Prozherina Y. | |||
| No 4 (2021) | Building a logical-semantic model of the choice of fixed combinations of drugs for treatment of hypertension | Abstract | |
| Ibragimova G.Y., Fedotova A.A., Iksanova G.R., Khasanova R.Y., Vasilchenko K.A. | |||
| No 4 (2018) | Business activity of medical industry enterprises: net profit rating 2016 | Abstract |
(Rus) |
| Romanova S. | |||
| No 4 (2018) | Business efficiency of enterprises in the pharmaceutical industry: net profit rating for 2016 | Abstract |
(Rus) |
| Romanova S. | |||
| No 4 (2018) | Business efficiency of enterprises in the pharmaceutical industry: net profit rating for 2016 | Abstract |
(Rus) |
| Romanova S. | |||
| No 5 (2018) | Business efficiency of enterprises in the pharmaceutical sector: 2016 net profit rating | Abstract |
(Rus) |
| Romanova S. | |||
| No 3 (2018) | Business efficiency of enterprises in the pharmaceutical sector: 2016 return on investment rating | Abstract |
(Rus) |
| Romanova S. | |||
| No 1-2 (2018) | Business efficiency of enterprises in the pharmaceutical sector: sales profit rating for 2016 | Abstract |
(Rus) |
| Romanova S. | |||
| No 6 (2018) | Business efficiency of enterprises in the pharmaceutical sector: stock turnover rating for 2016 | Abstract |
(Rus) |
| Romanova S. | |||
| No 1-2 (2018) | Business performance of pharma industry enterprises: 2016 equity turnover rating | Abstract |
(Rus) |
| Romanova S. | |||
| No 13S (2018) | Cerebrolysin® is currently enjoying a new lease on life | Abstract |
(Rus) |
| Prozherina J. | |||
| No 4 (2019) | CHALLENGES AND ISSUES IN OPERATING PERSONNEL MANAGEMENT DURING THE IMPLEMENTATION OF PHARMACEUTICAL QUALITY SYSTEM | Abstract |
(Rus) |
| SMIRNOV V.A., GORYACHKIN V.V., SHESTAKOV V.N., ABRAMOVICH R.A. | |||
| 1 - 100 of 814 Items | 1 2 3 4 5 6 7 8 9 > >> | ||
REMEDIUM
ISSN 1561-5936 (Print) ISSN 2658-3534 (Online) |
User
×
User